https://www.brighteon.com/852cad05-d8c0-4442-a9ce-bab2b494a6c4 Video Here with Del Bigtree
PFIZER COVID VACCINE FRENZY
Pfizer broke big news this week, that their #Covid19 Vaccine has proven 90% effective in trials. While all major news outlets are in a frenzy, Del has found some shocking information in the fine print.
- Analysis evaluated 94 confirmed cases of COVID-19 out of 43,538 participants. This is .2%. Repeat, only .2% reporting.
- They have not noted any serious safety concerns for only 2 months.
- While the study states it will evaluate the potential for the vaccine candidate to provide protection against COVID-19 in those who have had prior exposure to SARS-CoV-2, as well as prevention against severe COVID-19 disease, IT HASN’T YET DONE SO. Therefore, they have not yet obtained whether this vaccine does these things at all.
This is a complete joke. Don’t buy it.
This is just like the ‘Casedemic’ of COVID-19 based on faulty testing in which nearly everyone tests positive, yet have ZERO symptoms: https://madisonarealymesupportgroup.com/2020/11/12/fauci-states-covid-test-has-a-fatal-flaw-back-in-july-just-like-he-said-face-masks-were-useless-back-in-may/
For more:
- https://madisonarealymesupportgroup.com/2020/11/11/how-covid-19-vaccine-can-destroy-your-immune-system/
- https://madisonarealymesupportgroup.com/2020/10/05/covid-19-vaccine-explained/
- https://madisonarealymesupportgroup.com/2020/11/13/covid-plans-include-family-separation-involuntary-quarantine-in-camps/
This vaccine isn’t needed: https://madisonarealymesupportgroup.com/2020/09/24/studies-show-proper-levels-of-vitamin-d-slashes-risk-of-covid-as-does-gargling-with-iodine-vaccine-not-needed/
Lastly, please see:
https://www.bmj.com/content/371/bmj.m4258/rr
Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4258 (Published 09 November 2020)Cite this as: BMJ 2020;371:m4258
In 2009 they reached a fraud settlement with the U.S. Department of Justice for $2.3 BILLION, the largest ever fraud settlement in the history of the DOJ at that time. (Source.)
Since then, they have faced numerous other criminal investigations, the most recent one being reported just yesterday, November 10, 2020, with the foreign corruption units at the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) looking into their activities in China and Russia. https://healthimpactnews.com/2020/criminal-pfizer-inc-wins-covid-vaccine-race-hundreds-of-millions-of-doses-expected-to-be-ready-within-weeks/
According to Shilhavy:
It is very unlikely that Merck, AZ, J&J and Moderna are just going to sit back and let Pfizer dominate this new, lucrative COVID vaccine market. Look for similar press releases from those companies very soon, touting how effective their vaccines are as well, as they look to get their piece of the pie.
Pfizer’s stock has already soared, and market analysis is now predicting that due to this announcement their sales will now reach $258 million in the fourth quarter of 2020, with sales in 2021 expected to reach $4.6 BILLION. (Source.)
All of these companies have already received BILLIONS through Operation Warp Speed, so they will ALL come out ahead financially no matter what happens.
The real losers will be the citizens of the U.S. and other countries who receive these vaccines.
I couldn’t agree more.
Madison Area Lyme Support Group 
Rapid Response:
Re: Covid-19 vaccines: Many ADRs are already expected
Dear Editor
The Ted-tenders electronic daily: Supplement to the Official Journal of the EU, details a contract negotiated by the Medicines and Healthcare Products Agency (MHRA), dated 14.9.20 (1).
It states:
It further explains: “For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool…… it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine. Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively. This will hinder its ability to rapidly identify any potential safety issues with the Covid-19 vaccine and represents a direct threat to patient life and public health”.
Why do they expect that a high volume of ADRs will be generated?
And would it not be more sensible to determine the safety profile of a Covid-19 vaccine while the stable door is shut, rather than monitor the galloping horse once it has bolted?
(1) https://ted.europa.eu/udl?uri=TED:NOTICE:506291-2020:TEXT:EN:HTML&src=0
Competing interests: No competing interests